GENE ONLINE|News &
Danaher Corporation Completes Acquisition of Masimo Corporation on June 10, 2026
Danaher Corporation finalized its acquisition of Masimo Corporation on Wednesday, June 10, 2026. This transaction integrates Masimo’s medical technology portfolio into Danaher’s existing life sciences and diagnostics operations.
The completion of the deal follows the fulfillment of all customary closing conditions and regulatory requirements. By acquiring Masimo, Danaher adds a suite of non-invasive patient monitoring technologies and signal processing solutions to its business segments. The companies did not disclose the final financial terms of the transaction in the official announcement. Danaher management stated that the integration process will begin immediately to align Masimo’s product lines with the company’s broader diagnostic infrastructure.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 10, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
IBEC and European Researchers Receive Novo Nordisk Foundation Grant to Study Physics of Living Matter
2026-07-10
Manufacturers Integrate Commercial, Government, and Cash-Pay Strategies to Optimize Product Life Cycle Value
2026-07-10
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
